87.JPG)
The Neurovascular Embolization Devices Market Size is valued at USD 1.44 Billion in 2023 and is predicted to reach USD 2.41 Billion by the year 2031 at a 6.75% CAGR during the forecast period for 2024-2031.
These coils are prescription equipment implanted into the aneurysm sac by a physician to block blood flow and promote thrombosis. Since coil-treated aneurysms may have residual filling or recur, placing the patient at risk for late hemorrhage, follow-up imaging is done when post-procedure is required. Digital Subtraction Angiography (DSA) was traditionally the method used after coiling to imagine aneurysms. However, since improvements in image clarity and usability of MRA, many health care providers can opt to use MRA instead of DSA, so patients are not vulnerable to an embolic stroke or ionizing radiation hazards.
With the help of embolization coils and liquid embolic systems, healthcare companies in the neurovascular embolization devices (neurology) market have successfully laid a solid foundation for treatment options. However, with some health problems, such as wide-neck bifurcated aneurysms, specific therapeutic methods pose particular difficulties. Manufacturers are introducing monotherapy saccular implants to overcome this challenge. Centered on the same principle, healthcare companies are designing Woven EndoBridge (WEB) aneurysm embolization solutions in the neurovascular embolization devices (neurology) industry that resolve the complications associated with coil-assist devices and surgical clippings.
The neurovascular embolization devices market is a segment based on product type, end-user, and geography. In terms of product type, the global market is segregated into aneurysm clips, liquid embolic systems, flow diversion stents, embolization coils, and intravascular flow disruptors. The embolization coils product segment is expected to dominate the global neurovascular embolization devices (neurology) during the forecast period. The rapid acceptance and growing demand for embolization coils, since they are one of the oldest recognized embolization instruments, and well-trained interventional radiologists in conducting embolization procedures with these instruments since opposed to others, make them essential for specific embolization procedures.
Based on end-user, the global neurovascular embolization devices market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. Globally, the increase in the prevalence of stroke is projected to drive the global market for neurovascular embolization devices (neurology) during the forecast period. About 33 million people globally suffer from stroke, according to WHO, last year. In comparison, in low- and middle-income economies, 70 per cent of stroke and 87% of stroke-related injuries and mortalities exist. In addition, stroke incidence rates in low- and middle-income countries have more than doubled in the last four decades. Stroke is the second-largest cause of mortality and the third-largest cause of disability worldwide. The increase in prevalence and burden of stroke will drive the need for surgery, which is expected to accelerate the growth of the global market for neurovascular embolization devices (neurology) in the coming years.
Based on geography, the global neurovascular embolization devices market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. In terms of revenue, over the forecast period, North America is expected to account for a leading share of the global market for neurovascular embolization devices (neurology), owing to a rise in occurrence levels of neurovascular diseases, especially brain aneurysm, in the United States. According to the Brain Aneurysm Foundation, the brain aneurysm has been unbroken by 1 in 50 people, or 6 million individuals in the U.S. Every year around 30,000 people in the country suffer from rupture of cerebral aneurysm. That, in turn, is expected to drive the country’s demand for neurovascular embolization devices (neurology).
The Asia Pacific demand for neurovascular embolization devices (neurology) is expected to expand at a fast pace in the near future. Given the high prevalence of cerebrovascular disorders, unhealthy lifestyle choices such as smoking, bad diets, and high incidence of diabetes and hypertension, India and China are projected to be attractive markets during the forecast period,
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 1.44 Billion |
|
Revenue Forecast In 2031 |
USD 2.41 Billion |
|
Growth Rate CAGR |
CAGR of 6.75% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion, volume (units) and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Acandis GmBH, B. Braun, BALT Extrusion, Emboflu, Stryker, Johnson & Johnson (Cerenovus), KLS Martin, Medtronic Plc, Mizuho Medical, Peter Lazic GmBH, Phenox GmBH, Spartan Micro, Terumo Corporation (MicroVention) among others. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Neurovascular Embolization Devices Market Snapshot
Chapter 4. Global Neurovascular Embolization Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type, & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product Type:
5.2.1. Aneurysm Clips
5.2.2. Liquid Embolic Systems
5.2.3. Flow Diversion Stents
5.2.4. Embolization Coils
5.2.5. Intrasaccular Flow Disruptors
Chapter 6. Market Segmentation 2: By End-User Estimates & Trend Analysis
6.1. By End-User & Market Share, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-User:
6.2.1. Hospitals
6.2.2. Ambulatory Surgical Centers
6.2.3. Specialty Clinics
Chapter 7. Neurovascular Embolization Devices Market Segmentation 6: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Neurovascular Embolization Devices Market revenue (US$ Million) estimates and forecasts By Product Type, 2024- 2031
7.1.2. North America Neurovascular Embolization Devices Market revenue (US$ Million) estimates and forecasts By End-User, 2024- 2031
7.1.3. North America Neurovascular Embolization Devices Market revenue (US$ Million) estimates and forecasts by country, 2024- 2031
7.2. Europe
7.2.1. Europe Neurovascular Embolization Devices Market revenue (US$ Million) By Product Type, 2024- 2031
7.2.2. Europe Neurovascular Embolization Devices Market revenue (US$ Million) By End-User, 2024- 2031
7.2.3. Europe Neurovascular Embolization Devices Market revenue (US$ Million) by country, 2024- 2031
7.3. Asia Pacific
7.3.1. Asia Pacific Neurovascular Embolization Devices Market revenue (US$ Million) By Product Type, 2024- 2031
7.3.2. Asia Pacific Neurovascular Embolization Devices Market revenue (US$ Million) By End-User, 2024- 2031
7.3.3. Asia Pacific Neurovascular Embolization Devices Market revenue (US$ Million) by country, 2024- 2031
7.4. Latin America
7.4.1. Latin America Neurovascular Embolization Devices Market revenue (US$ Million) By Product Type, 2024- 2031
7.4.2. Latin America Neurovascular Embolization Devices Market revenue (US$ Million) By End-User, 2024- 2031
7.4.3. Latin America Neurovascular Embolization Devices Market revenue (US$ Million) by country, 2024- 2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Neurovascular Embolization Devices Market revenue (US$ Million) By Product Type, 2024- 2031
7.5.2. Middle East & Africa Neurovascular Embolization Devices Market revenue (US$ Million) By End-User, 2024- 2031
7.5.3. Middle East & Africa Neurovascular Embolization Devices Market revenue (US$ Million) by country, 2024- 2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Acandis GmBH
8.2.2. Braun
8.2.3. BALT Extrusion
8.2.4. Emboflu
8.2.5. Stryker
8.2.6. Johnson & Johnson (Cerenovus)
8.2.7. KLS Martin
8.2.8. Medtronic Plc
8.2.9. Mizuho Medical
8.2.10. Peter Lazic GmBH
8.2.11. Phenox GmBH
8.2.12. Spartan Micro
8.2.13. Terumo Corporation (MicroVention)
Global Neurovascular Embolization Devices Market Outlook (Value (US$ Mn) & Volume (no. of units)) By Product Type
Global Neurovascular Embolization Devices Market Outlook (Value (US$ Mn)) By End-Users
Global Neurovascular Embolization Devices Market Outlook (Value (US$ Mn) & Volume (no. of units)) By Region
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
